- Home
- LAMR vs EXAS Comparison
LAMR vs EXAS Comparison
Compare LAMR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAMR
- EXAS
- Stock Information
- Founded
- LAMR 1902
- EXAS 1995
- Country
- LAMR United States
- EXAS United States
- Employees
- LAMR N/A
- EXAS N/A
- Industry
- LAMR Real Estate Investment Trusts
- EXAS Medical Specialities
- Sector
- LAMR Real Estate
- EXAS Health Care
- Exchange
- LAMR Nasdaq
- EXAS Nasdaq
- Market Cap
- LAMR 12.5B
- EXAS 10.2B
- IPO Year
- LAMR 1996
- EXAS N/A
- Fundamental
- Price
- LAMR $127.29
- EXAS $52.57
- Analyst Decision
- LAMR Buy
- EXAS Strong Buy
- Analyst Count
- LAMR 5
- EXAS 22
- Target Price
- LAMR $134.20
- EXAS $67.38
- AVG Volume (30 Days)
- LAMR 541.5K
- EXAS 2.8M
- Earning Date
- LAMR 11-07-2025
- EXAS 11-04-2025
- Dividend Yield
- LAMR 4.90%
- EXAS N/A
- EPS Growth
- LAMR N/A
- EXAS N/A
- EPS
- LAMR 4.29
- EXAS N/A
- Revenue
- LAMR $2,234,298,000.00
- EXAS $2,939,949,000.00
- Revenue This Year
- LAMR $4.38
- EXAS $16.68
- Revenue Next Year
- LAMR $3.72
- EXAS $12.08
- P/E Ratio
- LAMR $29.49
- EXAS N/A
- Revenue Growth
- LAMR 3.23
- EXAS 12.55
- 52 Week Low
- LAMR $99.84
- EXAS $38.81
- 52 Week High
- LAMR $139.88
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- LAMR 52.43
- EXAS 54.29
- Support Level
- LAMR $125.75
- EXAS $46.30
- Resistance Level
- LAMR $128.88
- EXAS $56.52
- Average True Range (ATR)
- LAMR 2.00
- EXAS 1.44
- MACD
- LAMR -0.14
- EXAS -2.57
- Stochastic Oscillator
- LAMR 35.91
- EXAS 93.27
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.